x

No restraining SII from using Covishield name for vaccine: HC

Shortpedia

Content Team
Image Credit: Shortpedia

The Bombay High Court on Tuesday refused to restrain Serum Institute of India Private Limited from using the name 'Covishield' for its vaccine against COVID-19 noting that such an order would create confusion and disruption in the vaccine administration programme. A division bench of Justices Nitin Jamdar and C V Bhadang dismissed an appeal filed by pharmaceutical firm Cutis Biotech claiming trademark of the name 'Covishield.'